LOWERING OF DOPAMINE METABOLITES IN RAT-BRAIN BY HARMALINE

被引：3

作者：

FULLER, RW

HEMRICKLUECKE, SK

PERRY, KW

机构：

来源：

JOURNAL OF PHARMACY AND PHARMACOLOGY | 1981年 / 33卷 / 04期

关键词：

D O I：

10.1111/j.2042-7158.1981.tb13773.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：255 / 256

页数：2

共 19 条

[1] MONOAMINE OXIDASE-B INHIBITOR DEPRENYL POTENTIATES PHENYLETHYLAMINE BEHAVIOR IN RATS WITHOUT INHIBITION OF CATECHOLAMINE METABOLITE FORMATION [J].

BRAESTRUP, C ;

ANDERSEN, H ;

RANDRUP, A .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 34 (01) :181-187

[2] EFFECTS OF CHRONIC REGIMENS OF CLORGYLINE AND PARGYLINE ON MONO-AMINE METABOLISM IN THE RAT-BRAIN [J].

CAMPBELL, IC ;

ROBINSON, DS ;

LOVENBERG, W ;

MURPHY, DL .

JOURNAL OF NEUROCHEMISTRY, 1979, 32 (01) :49-55

[3]

DEMAREST KT, 1979, MONOAMINE OXIDASE ST, P423

[4] EXPLANATION FOR DEAMINATION OF PHENYLETHYLAMINE BY MULTIPLE TYPES OF MONO-AMINE OXIDASE [J].

DIAL, EJ ;

CLARKE, DE .

PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1979, 11 (06) :491-500

[5] MONOAMINE-OXIDASE A AND B - USEFUL CONCEPT [J].

FOWLER, CJ ;

CALLINGHAM, BA ;

MANTLE, TJ ;

TIPTON, KF .

BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) :97-101

[6] KINETIC STUDIES AND EFFECTS IN VIVO OF A NEW MONOAMINE OXIDASE INHIBITOR N-[2-(O-CHLOROPHENOXY)-ETHYL]-CYCLOPROPYLAMINE [J].

FULLER, RW .

BIOCHEMICAL PHARMACOLOGY, 1968, 17 (10) :2097-&

[7]

FULLER RW, 1978, P SOC EXP BIOL MED, V158, P323

[8] ENHANCED SELECTIVITY OF PARGYLINE AS AN INHIBITOR OF TYPE-B MONO-AMINE OXIDASE IN HARMALINE-TREATED RATS [J].

FULLER, RW ;

HEMRICK, SK .

LIFE SCIENCES, 1978, 22 (12) :1083-1086

[9]

FULLER RW, 1968, ARCH INT PHARMACOD T, V174, P32

[10] SOME OBSERVATIONS UPON A NEW INHIBITOR OF MONOAMINE OXIDASE IN BRAIN TISSUE [J].

JOHNSTON, JP .

BIOCHEMICAL PHARMACOLOGY, 1968, 17 (07) :1285-&

← 1 2 →